| Literature DB >> 24450656 |
Pablo Ivan Pereira Ramos, Renata Christina Picão, Luiz Gonzaga Paula de Almeida, Nicholas Costa B Lima, Raquel Girardello, Ana Carolina P Vivan, Danilo E Xavier, Fernando G Barcellos, Marsileni Pelisson, Eliana C Vespero, Claudine Médigue, Ana Tereza Ribeiro de Vasconcelos1, Ana Cristina Gales, Marisa Fabiana Nicolás.
Abstract
BACKGROUND: Klebsiella pneumoniae is an important opportunistic pathogen associated with nosocomial and community-acquired infections. A wide repertoire of virulence and antimicrobial resistance genes is present in K. pneumoniae genomes, which can constitute extra challenges in the treatment of infections caused by some strains. K. pneumoniae Kp13 is a multidrug-resistant strain responsible for causing a large nosocomial outbreak in a teaching hospital located in Southern Brazil. Kp13 produces K. pneumoniae carbapenemase (KPC-2) but is unrelated to isolates belonging to ST 258 and ST 11, the main clusters associated with the worldwide dissemination of KPC-producing K. pneumoniae. In this report, we perform a genomic comparison between Kp13 and each of the following three K. pneumoniae genomes: MGH 78578, NTUH-K2044 and 342.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24450656 PMCID: PMC3904158 DOI: 10.1186/1471-2164-15-54
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1Circular map of the chromosome of Kp13 and related bacteria. The innermost ring represents the K. pneumoniae Kp13 chromosome used as reference and its coordinates. The second ring (in black) plots the G + C content of the reference, followed by its G + C skew (in purple/green). Red, cyan and green rings that follow depict BLASTN comparisons between the chromosomes of Kp13 and those of strains MGH 78578, NTUH-K2044 and 342, respectively. The outermost, interspaced rings (in orange) represent the localization of the predicted regions of genomic plasticity in the Kp13 chromosome, and the labels of each region follow the ones in Table 2.
Main features of the Kp13 genome compared to related bacteria
| | | | | | | | |
| 5,307,003 | 57.5 | 5,288 | 896 | 89.3 | 86 | This study | |
| | | | | | | | |
| pKP13a | 2,459 | 49.2 | 3 | 553 | 67.5 | 0 | |
| pKP13b | 3,223 | 56.3 | 5 | 505 | 78.4 | 0 | |
| pKP13c | 5,065 | 43.8 | 9 | 350 | 62.3 | 0 | |
| pKP13d | 45,574 | 46.0 | 63 | 590 | 81.6 | 0 | |
| pKP13e | 81,071 | 51.1 | 108 | 636 | 84.8 | 0 | |
| pKP13f | 295,493 | 47.9 | 365 | 682 | 84.2 | 0 | |
| | | | | | | | |
| 5,248,520 | 57.7 | 5,130 | 939 | 89.4 | 86 | [ | |
| | | | | | | | |
| pK2044 | 224,152 | 50.2 | 270 | 696 | 83.4 | 0 | |
| | | | | | | | |
| 5,315,120 | 57.5 | 4,776 | 958 | 86.1 | 86 | Washington University | |
| | | | | | | | |
| pKPN3 | 175,879 | 51.7 | 178 | 756 | 76.5 | 0 | |
| pKPN4 | 107,576 | 53.4 | 123 | 726 | 83.1 | 0 | |
| pKPN5 | 88,582 | 53.8 | 98 | 694 | 76.8 | 0 | |
| pKPN6 | 4,259 | 41.4 | 5 | 551 | 64.7 | 0 | |
| pKPN7 | 3,478 | 45.7 | 5 | 343 | 49.3 | 0 | |
| | | | | | | | |
| 5,641,239 | 57.3 | 5,425 | 915 | 88.0 | 88 | [ | |
| | | | | | | | |
| pKP187 | 187,922 | 47.2 | 230 | 608 | 74.5 | 0 | |
| pKP91 | 91,096 | 51.1 | 113 | 635 | 78.8 | 0 |
‡Number of CDSs according to the submitted GenBank flatfile downloaded from NCBI for each studied genome.
Regions of Genomic Plasticity (RGPs) identified in the Kp13 chromosome
| RGP1 | 748,751 – 764,155 | 15.4 | 17 | 59% | s.b.; dGC%; transposases | |
| RGP2 | 1,031,543 – 1,043,427 | 11.9 | 9 | 37% | s.b.; dGC%; phage; transposases | |
| RGP3 | 1,294,343 – 1,335,472 | 41.1 | 55 | 52% | s.b.; dGC%; phage | |
| RGP4 | 1,444,954 – 1,481,531 | 36.6 | 36 | 50% | s.b.; dGC%; T6SS; tRNA; transposases | |
| RGP5 | 1,827,686 – 1,893,227 | 65.5 | 59 | 53% | s.b.; tRNA; dGC%; T4SS | |
| RGP6 | 2,056,825 – 2,088,335 | 31.5 | 35 | 52% | s.b.; T6SS; dGC%; transposases | |
| RGP7 | 2,278,838 – 2,293,758 | 14.9 | 17 | 46% | s.b.; dGC%; transposases | |
| RGP8 | 2,961,023 – 2,987,614 | 26.6 | 20 | 60% | s.b.; T6SS; dGC% | |
| RGP9 | 3,155,750 – 3,244,119 | 88.4 | 111 | 52% | s.b.; dGC%; phage | |
| RGP10 | 3,425,935 – 3,436,504 | 10.6 | 9 | 48% | s.b.; dGC%; transposases | |
| RGP11 | 3,898,258 – 3,906,459 | 8.2 | 9 | 54% | s.b.; transposases | |
| RGP12 | 4,204,889 – 4,234,405 | 29.5 | 33 | 48% | s.b.; dGC%; tRNA; transposases | |
| RGP13 | 4,660,071 – 4,695,371 | 35.3 | 32 | 50% | s.b.; dGC%; tRNA; transposases |
*BLASTN performed against the ‘nr’ database at the NCBI website; dGC%, deviation from mean chromosomal GC content; s.b., synteny break from at least one other compared K. pneumoniae; phage, probable bacteriophage region; tRNA, presence of flanking transfer RNAs; transposases, presence of transposase-related sequences; T4SS/T6SS, presence of, respectively, types IV/VI secretion systems.
Figure 2Genomic context of RGP5 (high-pathogenicity island) detected in Kp13. Arrows represent predicted genes and their respective transcription strands (forward/reverse). In yellow, those that code for T4SS proteins; in blue, genes unique to Kp13; in green, genes related to siderophore production and export. The central segment unique to NTUH-K2044 contains the iro cluster related to iron capture. In orange and brown are shown, respectively, integrases and transposases. Plots above each region indicates the corresponding G + C content (%). The vertical blue and red segments connecting regions represent, respectively, direct or inverted conserved segments (BLASTN ≥ 70%).
Figure 3Unique and shared gene content among the genomes of Kp13, NTUH-K2044, MGH 78578 and 342. The roman numbers at each partial intersection correspond to the CDSs in Additional file 4.
Characteristics of the beta-lactamases identified in the Kp13 genome
| Beta-lactamase SHV-12 | KP32248 | pKP13f | ||
| Beta-lactamase OXA-9 | KP01389 | pKP13f | ||
| Beta-lactamase TEM-1 | KP01391 | pKP13f | ||
| Beta-lactamase CTX-M-2 | KP03128 | pKP13f | ||
| Beta-lactamase SHV-110 | KP31849 | Chr | ||
| Beta-lactamase KPC-2 | KP06703 | pKP13d |
*,BLASTP against the NCBI database; Chr, chromosome; nd, not determined; pKP13[d/f], plasmid pKP13d/pKP13f.
Figure 4Genetic context of in Kp13. Genes are depicted as horizontal arrows (orientations indicate their transcriptional direction). Some structures of this region are highlighted, such as an inverted repeat right (IRR) of the Tn3 transposon, as well as inverted repeats flanking ISKpn6 (depicted as black triangles). Also shown are the localization of two rho-independent transcriptional terminators (T1, T2) identified using the ARNold webserver [49] and their corresponding sequences.
Drug-related efflux pumps identified in compared
| | | | | | | |
| AcrAB | KP03628 | AC, BL, BS, CM, CV, EB, FA, FQ, ML, NO, OS, RF, SDS, TX | + | + | + | + |
| AcrD | KP03833 | AG, DC, FU, NO | + | + | + | + |
| KexD | KP05076 | EM, EB, NO, RD, TPP | + | − | + | − |
| MdtABC | KP03148 | BS, DC, NO | + | + | + | + |
| OqxAB | KP02440 | CM, FQ, NA, SDS | + | + | + | + |
| | | | | | | |
| Bcr | KP04395 | BI, STZ | + | + | + | + |
| EmrAB | KP31576 | CCC, NA, TCS, TLM | + | + | + | + |
| Fsr | KP03612 | FM | + | + | + | + |
| MdfA (KdeA) | KP04269 | AG, BENZ, CM, EB, FQ, RF, TC | + | + | + | + |
| MdtG | KP04943 | DC, FOM | + | + | + | + |
| MdtH | KP04933 | ENX (FQ), NFX | + | + | + | + |
| MdtL | KP32205 | CM | + | + | + | + |
| SmvA | KP04515 | CV, EB | + | + | + | + |
| | | | | | | |
| EmrE | KP32244 | AC, CV, EB | + | − | − | − |
| SugE | KP00509 | BENZ, EB | + | + | + | + |
| | | | | | | |
| MdtK | KP05135 | AC, NFX | + | + | + | + |
| | | | | | | |
| MacAB | KP04225 | ML | + | + | + | + |
| MdlAB | KP03663 | ? | + | + | + | + |
∆, in the case where the pump is encoded by multiple CDSs, the ID corresponds to one of the adjacent CDSs. Ω, based in the literature found for each system. Substrate nomenclature adapted from [54]: AC, acriflavine; AG, aminoglycosides; BI, bicyclomycin; BL, beta-lactams; BS, bile salts; BENZ, benzalkonium chloride; CCC, carbonyl cyanide chlorophenylhydrazone; CM, chloramphenicol; CV, crystal violet; DC, deoxycholate; EB, ethidium bromide; EM, erythromycin; ENX, enoxacin; FA, fatty acids; FQ, fluoroquinolones; FOM, fosfomycin; FM, fosmidomycin; FU, fusidic acid; ML, macrolides; NA, nalidixic acid; NFX, norfloxacin; NO, novobiocin; OS, organic solvents; RD, rhodamine; RF, rifampicin; SDS, sodium dodecyl sulfate; STZ, sulfathiazole; TC, tetracycline; TCS, tetrachlorosalicylanilide; TLM, thiolactomycin; TPP, tetraphenylphosphonium chloride; TX, Triton X-100; ?, regarded as related to multidrug-resistance, but with an unknown resistance spectrum. *, evaluated by BLASTP against the target genome.
Figure 5Single-nucleotide polymorphisms (SNPs) identified in Kp13 compared to MGH 78578, NTUH-K2044 and 342 strains. (A) Total number of SNPs falling within non-coding and coding regions (CDSs) when compared with the three other strains. synon, synonymous. (B) Common SNPs falling within CDSs grouped by COG classification identified when compared with the strains NTUH-K2044 and MGH 78578. (C) Selected common SNPs falling within virulence- and resistance-related CDSs identified when compared with the NTUH-K2044 and MGH 78578 strains. MDR/DR, multidrug resistance/drug resistance; LPS, lipopolysaccharide. Numbers after the slash indicates the number of non-synonymous SNPs. COG classes single-letter abbreviations in panel B are: B (chromatin structure), C (energy production/conversion), D (cell division/chromosome partitioning), E (amino acid transport/metabolism), F (nucleotide transport/metabolism), G (carbohydrate transport/metabolism), H (coenzyme transport/metabolism), I (lipid transport/metabolism), J (translation/ribosomal structure), K (transcription), L (replication/recombination/repair), M (cell wall/membrane/envelope biogenesis), N (cell motility), O (posttranslational modification/protein turnover/chaperones), P (inorganic ion transport/metabolism), Q (secondary metabolite biosynthesis/transport/catabolism), R (general function prediction), S (function unknown), T (signal transduction), U (intracellular trafficking/secretion), V (defense mechanisms).